ProteinConjugates project deliverables
The page lists 28 deliverables related to the research project "ProteinConjugates".
List of Deliverables
| title and desprition | type | last update |
|---|---|---|
Project FinishEnd of the network programmed activities and research. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
A new GMP manufacturing platformGMP manufacturing platform for the construction of ADCs. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of sillafin based drug delivery systemsThe method involves the use of sillafin peptides to mediate delivery of cytotoxic drugs. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Summer SchoolOn the topic: The future of project conjugates as therapeutics. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of protein-based nanostructures modified with CAIX ligandsThe method involves the pre and post-site selective modificatiuon of proteins and their microfluidic assisted nanoparticle synthesis. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Evaluation of a new vascular targeting ADCEvaluation of a vascular targeting DM1-antibody L19. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Winter SchoolOn the topic: Advanced bioconjugation techniques. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of a new Transtuzumab-marine drug ADCThe ADC will be prepared via Transtuzumab-marine drug (PharmaMar) conjugation based on Cys site selective modification. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of a new Transtuzumab-SN38 ADCThe ADC will be prepared via Transtuzumab-SN38 conjugation based on Lys site selective modification. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of anti-MUC1-fluorofore conjugateThe method involves the site selective modification of a cysteine residue to incorporate a near infra-red dye. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of a new CXCR4-bortezomib ADCThe ADC will be prepared via CXCR4-bortezomib conjugation based on disulfide bridging with salicylhydroxamate. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of a new Fab (trastuzumab)-doxoribicin ADCThe ADCs will be prepared via Fab-Dox conjugation via disulfide bridging with pyridazinediones. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
New modified silaffins for drug-delivery based on silica nanoparticlesThe method involves the functionalization of silaffins with polyamides at lysine residues. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Construction of a new DM1-antibody L19 ADC vascular targeting ADCThe ADC will be prepared via DM1-antibody L19 ADC conjugation via trp site selective modification. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Evaluation of a new CXR4-bortezobib ADCIn vivo and in vitro evaluation of an CXVR4-borrtezomib ADC Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
Evaluation of a new homogeneous ADC against HER2In vivo and in vitro evaluation of a marine cytotoxic drugs conjugated to trastuzumab antibody. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-04-24 |
New method for the site-selective cysteine modificationThe method involves the site selective installation of boronic acids onto the protein via the formation of stable thioethers with modified styrenes and phenyloxadiazole methylsulfones. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
Website completionActivation of the ProteinConjugateswebsite. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Websites, patent fillings, videos etc. | 2020-01-15 |
New protein based nanoparticlesThe method involves the microfluidic aseembly and the chemical functionalization of proteins. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
A new method for disulfide bridging with boronic acid coordinating handlesThe method involves the installation of salicylhydroxamate handles site selectively on disulfide bonds Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
A new anti-MUC1-antibody 4 UR PDE PU 20 The method involves the design of a new anti-MUC1-antibody with high affinity and selectivity for modified MUC1 glycopeptidesThe method involves the design of a new anti-MUC1-antibody with high affinity and selectivity for modified MUC1 glycopeptides. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
Project Kick-offMeeting with the participation of all network members. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
New method for site-selective tryptophan modificationThe method involvs the Pd-(II) catalyzed, norbornene-mediated C−H activation reaction for selective alkylation at the C-2 indole position of Trp and selective formation of Caryl-N bonds at Trp. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
A new method for the disulphide bridgingThe method involves disulphide bridging disulfide bonds with pyridazinediones. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
New modified synthetic lectinsThe method involves the functionalization of synthetic lectins which recognize CRDs of cancer cells. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
New method for the site-selective lysine modificationThe method involves the use of 2-carbonylbenzeno BAs as amino blocking group and NHS reagents to append cargo. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
Construction of lectin based drug delivery systemsThe method involves the generation of synthetic lectins that bind to glycos phingolipids. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |
Vacancies advertisementAnnouncements of ProteinConjugates vacancies. Programme: H2020-EU.1.3.1. - Topic(s): MSCA-ITN-2015-ETN |
Other | 2020-01-15 |